I guess I hadn't thought of it that way. Since big pharma

New Post Public Reply Private Reply Replies (2) Message Board
Respert24 dejavu #89030
811
I guess I hadn't thought of it that way. Since big pharma is watching everything we do on this board I'd like to say a little something to them.

Hey BP,

My name is Respert24 and let me first just get out of the way that I'll accept a buyout at $129/share. It was $128 yesterday but when you snooze you looze, as our constitution so eloquently states. It's either in one of the amendments or possibly Leviticus. I can't remember. It's been decades since I learned all of that. But that one phrase always stuck with me, and I may be wrong, but it could be the first evidence in recorded history of people purposely spelling a word wrong to make it cooler. All of rap, from the 90's on, owes a debt of gratitude to the Lil ol' constitution. But where was I?

Oh yes, Big Pharma.

Long time no see, buddies! I used to work for a couple of you. Do you remember me? I launched the now recalled antibiotic Ketek, we partnered together on Ambien (me selling it and you constantly finding loopholes to keep the patent life going), and I was a part of the team selling Spiriva when it hit 2 BILLION in sales. I remember that clearly because as a gift for TWO BILLION in sales, I was able to choose one thing out of a "rewards" catalog of items. I never did use the $50 gift card to Crate & Barrel before it expired but that's not my point. My point is we're buds! Pals, mates, a third thing!

Now, as an investor I despise your control over the industry and influence with the FDA. But as someone eager for a new job I'd also like to offer my services should you need anyone to say, write a witty blog. Or a high paying sales job is ok too. But I get to pick the drugs. No butt stuff.

#NoButtStuff

Butt getting back on track the main thing I'd like to do is offer you the chance to partner with me on a buyout of CYDY. I will gladly help convince my fellow shareholders on this board to accept a payout that starts at $200/share. I know I said $129 a few moments ago but I did also warn you that when you snooze you looze.

You pay me a million dollars in Doge coin and I will help convince the squad that $300/share is possible. Once we get everyone on board I will leave you a coded message via tik tok and you can make your offer right away. I trust you have your tik tok decoder ring handy, because I code everything in Riverdance. (RIP Michael Flatley)

I trust you understand that your HIV drugs are no match. That your Covid therapies are garbage. I'll allow that you do a moderately decent job at cancer, but even that will be consumed by Leronlimab before long. There won't be much meat left on the bone if you don't make your move today. Act now and I'll throw in free shipping and handling and some Flex Tape. Maybe a Ronco Food Dehydrator.

Your Old Pal,

Respert24

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 3

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 0

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 4

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 0

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 1

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading

Top 5 Most Recently Viewed Articles

Jazz Pharmaceuticals Releases Promising Long-Term Ziihera Data

Updated Category News Views 148

Jazz Pharmaceuticals Announces Encouraging Ziihera Results Jazz Pharmaceuticals plc (NASDAQ: JAZZ) recently revealed significant data from their Phase 2 trial concerning Ziihera (zanidatamab-hrii). This research focuses on individuals battling HER2-positive metastatic gastroesophageal adenocarcinoma (mGEA) and has showcased a substantial long-term median overall survival...

Continue Reading
Dräger Achieves Perfect CMMC Level 2 Certification Success

Updated Category News Views 271

Dräger's Commitment to Cybersecurity Excellence In today’s digital age, ensuring the highest level of data security is crucial for organizations involved in medical and safety technologies. Recently, Dräger, a well-respected name in healthcare technology, accomplished a significant milestone by obtaining Cybersecurity Maturity Model Certification (CMMC) Level 2,...

Continue Reading
Nykredit Realkredit A/S Announces Key Coupon Rate Changes

Updated Category News Views 220

Understanding the Recent Coupon Rate Adjustments The financial market often sees adjustments in coupon rates, a critical element for investors. Nykredit Realkredit A/S, a notable player in the bond market, has announced modifications that will be effective from a future date. These changes will directly impact the floating-rate bonds issued by the company. Effective Date...

Continue Reading
Transformative IT Strategies for CIOs: Insights for 2025

Updated Category News Views 162

Shift from Disruption to Proactive Strategies for CIOs As 2025 unfolds, recent insights from Info-Tech Research Group reveal a transformative movement among IT leaders. These leaders are transitioning from mere reactive responses to disruptive challenges, embracing proactive strategies focused on artificial intelligence, cybersecurity, infrastructure development, and...

Continue Reading
Immix Biopharma to Showcase Innovative NXC-201 Research Soon

Updated Category News Views 104

Immix Biopharma to Present NXC-201 at Prominent Annual Meeting Immix Biopharma, Inc. (NASDAQ: IMMX), a leader in developing therapies for relapsed/refractory AL Amyloidosis, is excited to announce its upcoming presentation at a major annual meeting organized by the American Society of Hematology (ASH). The event will showcase the promising NXC-201 therapy, which focuses...

Continue Reading